Merck KGaA
[WKN: 659990 | ISIN: DE0006599905]
Aktienkurse
155,025€ -1,38%
Echtzeit-Aktienkurs Merck KGaA
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Aqilion regains rights to TAK1 program

AQILION AB (publ) announces that Aqilion and Merck have decided to terminate the joint development of the TAK1 program. Data…

Merck Overweight

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Merck KGaA mit einem Kursziel von 205 Euro…

5 Biggest Pharmaceutical ETFs in 2024

The global pharmaceutical market reached a total value of US$1.6 trillion in 2023, according to Statista, up significantly from the…

Merck acquires EyeBio in up to $3B deal

Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal…